These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

594 related items for PubMed ID: 23478562

  • 1. Acute mountain sickness prophylaxis: a high-altitude perspective.
    DeLellis SM, Anderson SE, Lynch JH, Kratz K.
    Curr Sports Med Rep; 2013; 12(2):110-4. PubMed ID: 23478562
    [Abstract] [Full Text] [Related]

  • 2. [Mountaineering and altitude sickness].
    Maggiorini M.
    Ther Umsch; 2001 Jun; 58(6):387-93. PubMed ID: 11441701
    [Abstract] [Full Text] [Related]

  • 3. Acetazolamide plus low-dose dexamethasone is better than acetazolamide alone to ameliorate symptoms of acute mountain sickness.
    Bernhard WN, Schalick LM, Delaney PA, Bernhard TM, Barnas GM.
    Aviat Space Environ Med; 1998 Sep; 69(9):883-6. PubMed ID: 9737760
    [Abstract] [Full Text] [Related]

  • 4. Findings of Cognitive Impairment at High Altitude: Relationships to Acetazolamide Use and Acute Mountain Sickness.
    Phillips L, Basnyat B, Chang Y, Swenson ER, Harris NS.
    High Alt Med Biol; 2017 Jun; 18(2):121-127. PubMed ID: 28509579
    [Abstract] [Full Text] [Related]

  • 5. The effects of a 5-lipoxygenase inhibitor on acute mountain sickness and urinary leukotriene e4 after ascent to high altitude.
    Grissom CK, Richer LD, Elstad MR.
    Chest; 2005 Feb; 127(2):565-70. PubMed ID: 15705997
    [Abstract] [Full Text] [Related]

  • 6. Acetazolamide and high altitude diseases.
    Bradwell AR, Wright AD, Winterborn M, Imray C.
    Int J Sports Med; 1992 Oct; 13 Suppl 1():S63-4. PubMed ID: 1483796
    [Abstract] [Full Text] [Related]

  • 7. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT).
    Gertsch JH, Basnyat B, Johnson EW, Onopa J, Holck PS.
    BMJ; 2004 Apr 03; 328(7443):797. PubMed ID: 15070635
    [Abstract] [Full Text] [Related]

  • 8. MEDEX 2015: Heart Rate Variability Predicts Development of Acute Mountain Sickness.
    Sutherland A, Freer J, Evans L, Dolci A, Crotti M, Macdonald JH.
    High Alt Med Biol; 2017 Sep 03; 18(3):199-208. PubMed ID: 28418725
    [Abstract] [Full Text] [Related]

  • 9. [Prevention and therapy of altitude sickness].
    Maggiorini M.
    Ther Umsch; 1993 Apr 03; 50(4):221-7. PubMed ID: 8378872
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological prevention of acute mountain sickness. Same ascent rates must be used to assess effectiveness of different doses of acetazolamide.
    Bärtsch P, Schneider M.
    BMJ; 2001 Jan 06; 322(7277):48-9. PubMed ID: 11141168
    [No Abstract] [Full Text] [Related]

  • 11. Altitude illness: risk factors, prevention, presentation, and treatment.
    Fiore DC, Hall S, Shoja P.
    Am Fam Physician; 2010 Nov 01; 82(9):1103-10. PubMed ID: 21121556
    [Abstract] [Full Text] [Related]

  • 12. Acute mountain sickness prophylaxis: knowledge, attitudes, & behaviours in the Everest region of Nepal.
    Kilner T, Mukerji S.
    Travel Med Infect Dis; 2010 Nov 01; 8(6):395-400. PubMed ID: 21112541
    [Abstract] [Full Text] [Related]

  • 13. Acute mountain sickness in travelers who consulted a pre-travel clinic.
    Croughs M, Van Gompel A, Van den Ende J.
    J Travel Med; 2011 Nov 01; 18(5):337-43. PubMed ID: 21896098
    [Abstract] [Full Text] [Related]

  • 14. Determinants of summiting success and acute mountain sickness on Mt Kilimanjaro (5895 m).
    Davies AJ, Kalson NS, Stokes S, Earl MD, Whitehead AG, Frost H, Tyrell-Marsh I, Naylor J.
    Wilderness Environ Med; 2009 Nov 01; 20(4):311-7. PubMed ID: 20030437
    [Abstract] [Full Text] [Related]

  • 15. Acetazolamide for the prevention of acute mountain sickness--a systematic review and meta-analysis.
    Ritchie ND, Baggott AV, Andrew Todd WT.
    J Travel Med; 2012 Nov 01; 19(5):298-307. PubMed ID: 22943270
    [Abstract] [Full Text] [Related]

  • 16. Day of Ascent Dosing of Acetazolamide for Prevention of Acute Mountain Sickness.
    Lipman GS, Jurkiewicz C, Winstead-Derlega C, Navlyt A, Burns P, Walker A, Phillips C, Reilly A, Burnier A, Romero J, Warner K, Hackett P.
    High Alt Med Biol; 2019 Sep 01; 20(3):271-278. PubMed ID: 31259608
    [Abstract] [Full Text] [Related]

  • 17. Statistical models of acute mountain sickness.
    Vann RD, Pollock NW, Pieper CF, Murdoch DR, Muza SR, Natoli MJ, Wang LY.
    High Alt Med Biol; 2005 Sep 01; 6(1):32-42. PubMed ID: 15772498
    [Abstract] [Full Text] [Related]

  • 18. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.
    Chow T, Browne V, Heileson HL, Wallace D, Anholm J, Green SM.
    Arch Intern Med; 2005 Feb 14; 165(3):296-301. PubMed ID: 15710792
    [Abstract] [Full Text] [Related]

  • 19. Acetazolamide or dexamethasone use versus placebo to prevent acute mountain sickness on Mount Rainier.
    Ellsworth AJ, Meyer EF, Larson EB.
    West J Med; 1991 Mar 14; 154(3):289-93. PubMed ID: 2028586
    [Abstract] [Full Text] [Related]

  • 20. Ginkgo biloba decreases acute mountain sickness in people ascending to high altitude at Ollagüe (3696 m) in northern Chile.
    Moraga FA, Flores A, Serra J, Esnaola C, Barriento C.
    Wilderness Environ Med; 2007 Mar 14; 18(4):251-7. PubMed ID: 18076292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.